Involvement of nuclear factor κB (NF-κB) in the downregulation of cyclo-oxygenase-2 (COX-2) by genistein in gastric cancer cells

Journal of International Medical Research

Volumn 39, Issue 6, 2011, Pages 2141-2150

  Li, Y S ^a   Wu, L P ^a,b   Li, K H ^a   Liu, Y P ^a   Xiang, R ^a   Zhang, S B ^a   Zhu, L Y ^a   Zhang, L Y ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Shenzhen Maternity and Child Healthcare Hospital   (China)

Author keywords

Apoptosis; Cyclo oxygenase 2 (COX 2); Gastric cancer; Genistein; Human gastric cancer cell line BGC 823; Isoflavone; Nuclear factor B (NF B)

Indexed keywords

CYCLOOXYGENASE 2; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DNA BINDING; STOMACH CANCER; WESTERN BLOTTING;

EID: 84555204269     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900610     Document Type: Article

References (30)

1. Leung WK, Wu MS, Kakugawa Y, et al: Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 3: 279-287.
2. Hawk ET, Umar A, Viner JL: Colorectal cancer chemoprevention-an overview of the science. Gastroenterology 2004; 126: 1423-1447.
3. Oki T, Sowa Y, Hirose T, et al: Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line. FEBS Lett 2004; 577: 55-59.
4. Shon YH, Park SD, Nam KS: Effective chemopreventive activity of genistein against human breast cancer cells. J Biochem Mol Biol 2006; 39: 448-451.
5. Yu Z, Tang Y, Hu D, et al: Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-β1/Smad pathway. Biochem Biophys Res Commun 2005; 333: 827-832.
6. Zou H, Zhan S, Cao K: Apoptotic activity of genistein on human lung adenocarcinoma SPC-A-1 cells and preliminary exploration of its mechanisms using microarray. Biomed Pharmacother 2008; 62: 583-589.
7. Choi EJ, Kim T, Lee MS: Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells. Life Sci 2007; 80: 1403-1408.
8. Méric JB, Rottey S, Olaussen K, et al: Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol 2006; 59: 51-64.
9. Jiang WG, Douglas-Jones A, Mansel RE: Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 275-281.
10. Muñoz-Espada AC, Watkins BA: Cyanidin attenuates PGE2 production and cyclooxygenase-2 expression in LNCaP human prostate cancer cells. J Nutr Biochem 2006; 17: 589-596.
11. Ohta T, Takahashi M, Ochiai A: Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers. Cancer Lett 2006; 239: 246-253.
12. Fang HY, Lin TS, Lin JP, et al: Cyclooxygenase-2 in human non-small cell lung cancer. Eur J Surg Oncol 2003; 29: 171-177.
13. Yamac D, Ayyildiz T, Coškun U, et al: Cyclooxgenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma. Pathol Res Pract 2008; 204: 527-536.
14. Tanabe T, Tohnai N: Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 2002; 68-69: 95-114.
15. Yan Z, Stapleton PP, Freeman TA, et al: Enhanced expression of cyclooxygenase-2 and prostaglandin E2 in response to endotoxin after trauma is dependent on MAPK and NF-κB mechanisms. Cell Immunol 2004; 232: 116-126.
16. Lee KM, Kang BS, Lee HL, et al: Spinal NF-κB activation induces COX-2 upregulation and contributes to inflammatory pain hyper- sensitivity. Eur J Neurosci 2004; 19: 3375-3381.
17. Baxa DM, Yoshimura FK: Genistein reduces NF- κB in T lymphoma cells via a caspase-mediated cleavage of I κBα. Biochem Pharmacol 2003; 66: 1009-1018.
18. Jin S, Lu D, Ye S, et al: A simplified probe preparation for ELISA-based NF-κB activity assay. J Biochem Biophys Methods 2005; 65: 20-29.
19. Zhou HB, Chen JJ, Wang WX, et al: Apoptosis of human primary gastric carcinoma cells induced by genistein. World J Gastroenterol 2004; 10: 1822-1825.
20. Cui HB, Na XL, Song DF, et al: Blocking effects of genistein on cell proliferation and possible mechanism in human gastric carcinoma. World J Gastroenterol 2005; 11: 69-72.
21. Ravindranath MH, Muthugounder S, Presser N, et al: Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 2004; 546: 121-165.
22. Tatsuguchi A, Matsui K, Shinji Y, et al: Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol 2004; 35: 488-495.
23. Zhang J, Ji J, Yuan F, et al: Cyclooxygenase-2 expression is associated with VEGF-C and lymph node metastases in gastric cancer patients. Biomed Pharmacother 2005; 59 (suppl 2): S285-S288.
24. Fujimura T, Ohta T, Oyama K, et al: Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers. J Gastrointest Cancer 2007; 38: 78-82.
25. Lee J, Im YH, Jung HH, et al: Curcumin inhibits interferon-α induced NF-κB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 2005; 334: 313-318.
26. Sarkar D, Saha P, Gamre S, et al: Anti- inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-κB pathway. Int Immunopharmacol 2008; 8: 1264-1271.
27. Yang GZ, Li L, Ding HY, et al: Cyclooxygenase- 2 is over-expressed in Chinese esophageal squamous cell carcinoma, and correlated with NF-κB: an immunohistochemical study. Exp Mol Pathol 2005; 79: 214-218.
28. Yoon JM, Lim JJ, Yoo CG, et al: Adenovirus- uteroglobin suppresses COX-2 expression via inhibition of NF-κB activity in lung cancer cells. Lung Cancer 2005; 48: 201-209.
29. Huang TH, Tran VH, Duke RK, et al: Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-κB activation. J Ethnopharmacol 2006; 104: 149-155.
30. Banerjee S, Li Y, Wang Z, et al: Multi-targeted therapy of cancer by genistein. Cancer Lett 2008; 269: 226-242.